Sonoma Pharmaceuticals Files for Up to $63.4 Million Mixed Shelf - (Fidelity via NewsPoints Desk)

  • Sonoma Pharmaceuticals filed a registration statement for the potential sale of up to $63.4 million in securities, as reported in Fidelity.

  • The securities include common shares, preferred shares, debt securities, warrants and units, according to the filing.

  • Net proceeds from the sale will be used for general corporate purposes, including working capital, capital expenditures, as well as research and development.

To read more NewsPoints articles, click here.